CoastWatcher
Moderator
A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel. The verdict was the third to date in US federal court in litigation over AndroGel, a drug approved for men whose bodies produce low or no testosterone that has become the subject of lawsuits by thousands of people.
AbbVie says it faces 4,510 cases nationally over injuries blamed on AndroGel. The verdict came in one of a series of test trials in federal litigation over AndroGel aimed at helping both sides gauge the range of damages and define settlement options.
"AbbVie wins U.S. trial in lawsuit over AndroGel's risks," Business Insider, http://www.businessinsider.com/r-ab...lawsuit-over-androgels-risks-2018-1?r=UK&IR=T
AbbVie says it faces 4,510 cases nationally over injuries blamed on AndroGel. The verdict came in one of a series of test trials in federal litigation over AndroGel aimed at helping both sides gauge the range of damages and define settlement options.
"AbbVie wins U.S. trial in lawsuit over AndroGel's risks," Business Insider, http://www.businessinsider.com/r-ab...lawsuit-over-androgels-risks-2018-1?r=UK&IR=T
